INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 April 2011
|
Total net assets |
£102.9m |
|
NAV per share |
176.1p |
|
Share price |
153.5p |
|
Total value of unquoted investments |
£24.3m |
|
Total number of portfolio companies |
59 |
|
Cash |
(4)% NAV |
|
Cash committed and reserved to unquoted investments |
8% NAV |
|
Portfolio companies with < 1 year of cash |
12% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
6.19 |
|
Shire Ltd |
6.14 |
|
Celgene |
5.81 |
|
Cadent |
5.31 |
|
Insulet |
4.77 |
|
Gilead Sciences |
4.64 |
|
Teva |
4.27 |
|
Micromet |
4.12 |
|
Biomarin |
2.9 |
|
Alexion |
2.9 |
|
|
----------- |
|
Total |
47.05 |
|
Geographical Allocation |
% |
|
United States |
73 |
|
Europe |
25 |
|
Middle East |
4 |
|
Australia |
2 |
|
Cash |
(4) |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
80 |
|
Unquoted |
24 |
|
Cash |
(4) |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 MAY 2011